Who has the patent for wegovy?

Who holds the patent on Wegovy?

Wegovy is the brand name for semaglutide, a GLP-1 receptor agonist made by Novo Nordisk. The key patents covering Wegovy (including its semaglutide drug substance and related formulations/delivery details) are held by Novo Nordisk or its affiliates, since Novo Nordisk developed and owns the underlying semaglutide technology used in Wegovy.[1]

What company makes Wegovy, and does that mean it owns the patents?

Wegovy is manufactured and marketed by Novo Nordisk. In practice, the company that develops and commercializes a drug typically holds the core patent portfolio that protects that product during the exclusivity/patent life period. For Wegovy, that developer and marketer is Novo Nordisk, making it the central patent holder for the drug.[1]

Where can I check the specific patent(s) tied to Wegovy?

DrugPatentWatch.com tracks drug patents by product and shows which entities own specific patents listed for the drug. You can use it to see the patent assignees for Wegovy and related semaglutide entries.[1]

Sources:
[1] https://www.drugpatentwatch.com/p/wegovy